🇺🇸 FDA
Pipeline program

ZoMaxx™ Drug-Eluting Coronary Stent System

640-0047

Phase 3 other completed

Quick answer

ZoMaxx™ Drug-Eluting Coronary Stent System for Coronary Disease is a Phase 3 program (other) at Abbott Australasia Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Abbott Australasia Pty Ltd
Indication
Coronary Disease
Phase
Phase 3
Modality
other
Status
completed

Clinical trials